Andrew J Hanzlik, MD PA | |
2215 North Blvd West, Davenport, FL 33837 | |
(863) 421-9898 | |
(863) 421-8979 |
Full Name | Andrew J Hanzlik |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 34 Years |
Location | 2215 North Blvd West, Davenport, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588736474 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | ME73735 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Adventhealth Orlando | Orlando, FL | Hospital |
Entity Name | Andrew J. Hanzlik, M.d., P.a |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124378229 PECOS PAC ID: 1456500040 Enrollment ID: O20120925000340 |
News Archive
Kaiser Health News staff writer Aimee Miles reports: "The whole idea behind HHS' Hospital Compare is simple: patients can shop around by putting in their zip codes and the website churns out a list of nearby hospitals, with detail on available services, care outcomes, patient satisfaction ratings and more.
In a pioneer study published in the latest issue of the scientific journal Nature Communications, a research team at the Instituto Gulbenkian de Ci-ncia (IGC; Portugal), led by Miguel Godinho Ferreira in collaboration with Isabel Gordo, show for the first time that chromosomes rearrangements (such as inversions or translocations) can provide advantages to the cells that harbor them depending on the environment they are exposed.
Saladax Biomedical, Inc. announced today that it has entered into a multi-year development and commercialization agreement with Bristol-Myers Squibb Company for the development of certain clinical diagnostic tests to be used in conjunction with the development of certain therapeutic compounds in the Bristol-Myers Squibb pipeline.
Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration, and systems tests of Signature Mapping TBDx™ (TBDx™) in preparation for September clinical trials in South Africa.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Andrew J Hanzlik, MD PA Po Box 470788, Celebration, FL 34747-0788 Ph: (863) 421-9898 | Andrew J Hanzlik, MD PA 2215 North Blvd West, Davenport, FL 33837 Ph: (863) 421-9898 |
News Archive
Kaiser Health News staff writer Aimee Miles reports: "The whole idea behind HHS' Hospital Compare is simple: patients can shop around by putting in their zip codes and the website churns out a list of nearby hospitals, with detail on available services, care outcomes, patient satisfaction ratings and more.
In a pioneer study published in the latest issue of the scientific journal Nature Communications, a research team at the Instituto Gulbenkian de Ci-ncia (IGC; Portugal), led by Miguel Godinho Ferreira in collaboration with Isabel Gordo, show for the first time that chromosomes rearrangements (such as inversions or translocations) can provide advantages to the cells that harbor them depending on the environment they are exposed.
Saladax Biomedical, Inc. announced today that it has entered into a multi-year development and commercialization agreement with Bristol-Myers Squibb Company for the development of certain clinical diagnostic tests to be used in conjunction with the development of certain therapeutic compounds in the Bristol-Myers Squibb pipeline.
Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration, and systems tests of Signature Mapping TBDx™ (TBDx™) in preparation for September clinical trials in South Africa.
› Verified 3 days ago